Home  »  Companies   »  Zimmer Biomet Holdings Inc. (ZBH) Is Now En Route ...

Zimmer Biomet Holdings Inc. (ZBH) Is Now En Route to Higher Prices

Zimmer Biomet Holdings Inc. (NYSE: ZBH) is -1.22% lower on its value in year-to-date trading and has touched a low of $100.39 and a high of $135.05 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ZBH stock was last observed hovering at around $124.09 in the last trading session, with the day’s gains setting it 1.85% off its average median price target of $127.50 for the next 12 months. It is also 13.14% off the consensus price target high of $145.00 offered by 27 analysts, but current levels are -25.94% lower than the price target low of $100.00 for the same period.

Currently trading at $125.94, the stock is 0.34% and 3.33% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.3 million and changing 1.49% at the moment leaves the stock 9.24% off its SMA200. ZBH registered 5.51% gain for a year compared to 6-month gain of 17.70%.

5 Undervalued Stocks For 2023

Approximately 544 miles north of Las Vegas lies what's been dubbed "the biggest lithium deposit in the US." One tiny company stands to be the biggest beneficiary because lithium "faces a long-term supply shortage," according to Barron's. This company, however, is sitting on a goldmine opportunity as it plans to produce 30,000 tonnes per annum over the next 3.5 years from this single deposit. Supplying the electric vehicle boom and potentially driving its stock price off the charts. But this is just one of the opportunities we have researched in our free report. The other four companies have just as much potential.

Click here to download your Free Copy…


The stock witnessed a 0.41% loss in the last 1 month and extending the period to 3 months gives it a 18.44%, and is 2.07% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.64% over the week and 1.87% over the month.

Zimmer Biomet Holdings Inc. (ZBH) has around 19500 employees, a market worth around $25.97B and $7.15B in sales. Current P/E ratio is 78.37 and Fwd P/E is 18.09. Profit margin for the company is 3.90%. Distance from 52-week low is 25.45% and -6.75% from its 52-week high. The company has generated returns on investments over the last 12 months (3.20%).

Zimmer Biomet Holdings Inc. (ZBH) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Zimmer Biomet Holdings Inc. (ZBH) is a “Hold”. 27 analysts offering their recommendations for the stock have an average rating of 2.90, where 16 rate it as a Hold and 2 think it is a “Overweight”. 5 of the analysts rate the stock as a “Buy”. 2 analysts have rated the stock as a Sell or Underperform.

Zimmer Biomet Holdings Inc. is expected to release its quarterly report on 05/02/2023.The EPS is expected to grow by 395.20% this year.

Zimmer Biomet Holdings Inc. (ZBH) Top Institutional Holders

The shares outstanding are 209.80M, and float is at 209.70M with Short Float at 1.44%.

Zimmer Biomet Holdings Inc. (ZBH) Insider Activity

A total of 9 insider transactions have happened at Zimmer Biomet Holdings Inc. (ZBH) in the last six months, with sales accounting for 5 and purchases happening 4 times. The most recent transaction is an insider sale by Phipps Chad F,the company’sSr. VP/Gen Counsel/Secretary. SEC filings show that Phipps Chad F sold 11,522 shares of the company’s common stock on Dec 13 at a price of $128.63 per share for a total of $1.48 million. Following the sale, the insider now owns 41880.0 shares.

Zimmer Biomet Holdings Inc. disclosed in a document filed with the SEC on Jul 05 that VAN ZUILEN WILFRED (Pres, Europe, M. East & Africa) sold a total of 531 shares of the company’s common stock. The trade occurred on Jul 05 and was made at $105.22 per share for $55870.0. Following the transaction, the insider now directly holds 2240.0 shares of the ZBH stock.

Still, SEC filings show that on Mar 17, Phipps Chad F (Sr. VP/Gen Counsel/Secretary) disposed off 35,149 shares at an average price of $121.97 for $4.29 million. The insider now directly holds 41,539 shares of Zimmer Biomet Holdings Inc. (ZBH).

Zimmer Biomet Holdings Inc. (ZBH): Who are the competitors?

The company’s main competitors (and peers) include Johnson & Johnson (JNJ) that is trading 1.85% up over the past 12 months and Medtronic plc (MDT) that is -22.37% lower over the same period. Stryker Corporation (SYK) is 0.18% up on the 1-year trading charts.

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts